FA
GILD icon

Financial Avengers’s Gilead Sciences GILD Stock Holding History

Financial Avengers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
1,344
+9
+0.7% +$1.19K 0.07% 40
2026
Q1 		$186K Buy
1,335
+8
+0.6% +$1.12K 0.08% 36
2025
Q4 		$163K Buy
1,327
+8
+0.6% +$972 0.07% 37
2025
Q3 		$146K Buy
1,319
+9
+0.7% +$1.02K 0.06% 38
2025
Q2 		$145K Buy
1,310
+10
+0.8% +$1.06K 0.07% 38
2025
Q1 		$146K Sell
1,300
-30
-2% -$3.1K 0.07% 40
2024
Q4 		$123K Buy
1,330
+11
+0.8% +$990 0.06% 43
2024
Q3 		$111K Buy
1,319
+12
+0.9% +$916 0.05% 45
2024
Q2 		$89.7K Buy
1,307
+14
+1% +$934 0.05% 44
2024
Q1 		$94.2K Buy
1,293
+13
+1% +$1K 0.05% 44
2023
Q4 		$104K Buy
1,280
+12
+0.9% +$934 0.06% 40
2023
Q3 		$95K Buy
1,268
+13
+1% +$1K 0.06% 43
2023
Q2 		$96.8K Buy
1,255
+12
+1% +$957 0.06% 43
2023
Q1 		$103K Buy
1,243
+11
+0.9% +$911 0.08% 36
2022
Q4 		$106K Buy
1,232
+10
+0.8% +$792 0.09% 34
2022
Q3 		$75K Buy
1,222
+14
+1% +$883 0.06% 41
2022
Q2 		$75K Buy
1,208
+15
+1% +$929 0.06% 43
2022
Q1 		$71K Sell
1,193
-948
-44% -$60.6K 0.04% 47
2021
Q4 		$155K Sell
2,141
-17
-0.8% -$1.17K 0.1% 36
2021
Q3 		$151K Sell
2,158
-229
-10% -$16.1K 0.1% 35
2021
Q2 		$164K Buy
2,387
+24
+1% +$1.6K 0.11% 34
2021
Q1 		$153K Sell
2,363
-130
-5% -$8.38K 0.11% 34
2020
Q4 		$145K Buy
+2,493
New +$150K 0.12% 29

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Avengers's GILD Position: Q2 2026 in Review

Financial Avengers increased its Gilead Sciences (GILD) stake by 0.67% in Q2 2026, buying an estimated $1.19K and bringing the position to 1,344 shares worth $170K. The position accounts for 0.07% of the portfolio, ranked #40.

Financial Avengers first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $186K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Financial Avengers held 1,344 shares of Gilead Sciences worth $170K as of Q2 2026.
  • Financial Avengers bought 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
  • Gilead Sciences made up 0.07% of Financial Avengers's portfolio in Q2 2026, its #40 holding.
  • Financial Avengers first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Financial Avengers's Gilead Sciences position peaked at $186K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Avengers's 13F filing for Q2 2026, filed 19 Aug 2026.